COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY
申请人:Azimioara Mihai
公开号:US20110190263A1
公开(公告)日:2011-08-04
The invention provides compounds of Formula (I): pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of GPR119.
N-aryltetrahydroisoquinoline derivatives as HA-CD44 interaction inhibitors: Design, synthesis, computational studies, and antitumor effect
作者:Jose M. Espejo-Román、Belén Rubio-Ruiz、Meriem Chayah-Ghaddab、Carlos Vega-Gutierrez、Gracia García-García、Arantza Muguruza-Montero、Carmen Domene、Rosario M. Sánchez-Martín、Olga Cruz-López、Ana Conejo-García
DOI:10.1016/j.ejmech.2023.115570
日期:2023.10
US5389638A
申请人:——
公开号:US5389638A
公开(公告)日:1995-02-14
[EN] TETRAHYDROISOQUINOLINES AS ALPHA-2 ANTAGONISTS AND BIOGENIC AMINE UPTAKE INHIBITORS<br/>[FR] TETRAHYDROISOQUINOLEINES EN TANT QU'ANTAGONISTES D'ALPHA-2 ET INHIBITEURS DE L'ASSIMILATION D'AMINES BIOGENIQUES
申请人:ABBOTT LABORATORIES
公开号:WO1995007260A1
公开(公告)日:1995-03-16
(EN) The present invention provides a tetrahydroisoquinoline compound of formula (I) or a pharmaceutically acceptable salt thereof which is an antagonist for alpha-2 adrenoreceptors and/or which inhibits biogenic amine uptake.(FR) L'invention concerne un composé de tétrahydroisoquinoléine représenté par la formule (I) ou un de ses sels pharmaceutiquement acceptable, lequel est un antagoniste des adrénorécepteurs alpha-2 et/ou inhibe l'assimilation d'amines biogéniques.